RxDoctor Payments Data

Terry Hunter

Psychiatric/Mental Health · Flint, MINPI 1588321020

Payments from drug & device makers

$1,149in general payments, 2019–2025

Across 52 payments — averaging $22.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$268
  • Neurocrine Biosciences, Inc.$169
  • E.r. Squibb & Sons, L.L.C.$152
  • Indivior Inc.$139
  • Lundbeck LLC$83
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$63
  • plus $274 from 7 others

What the payments were for

  • Food & beverage$1,10096%
  • Education$494%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,149 in reported general payments places this provider in the 65th percentile of 638 psychiatric/mental health providers in Michigan.

See all psychiatric/mental health providers in Michigan

Medicare billing

Part B allowed, 2024
$8,951
Medicare patients
25
Services billed
99

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate25$202,203
VraylarCariprazine Hcl51$72,699
Lurasidone Hcl110$22,225
TrintellixVortioxetine Hydrobromide45$21,061
BelsomraSuvorexant13$5,471
Paliperidone ErPaliperidone37$3,514
Quetiapine Fumarate ErQuetiapine Fumarate32$3,050
Buspirone Hcl180$2,565
Hydroxyzine Hcl180$2,529
Bupropion XlBupropion Hcl159$2,394
Vilazodone Hcl20$2,324
Aripiprazole121$2,287
Trazodone Hcl255$2,263
Alprazolam279$1,934
Quetiapine Fumarate201$1,892

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$169$202,20325 claims
AbbVieVraylar$46$72,69951 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 638 psychiatric/mental health providers in Michigan.

Other psychiatric/mental health in Flint

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →